Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma

Bone Marrow Transplantation

Volumn 24, Issue 12, 1999, Pages 1359-1361

  Dowell, J E ^a,b   Moots, P L ^a   Stein, R S ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Allogeneic bone marrow transplant; Graft versus host disease; Lymphoblastic lymphoma; Myasthenia gravis

Indexed keywords

CHOLINESTERASE INHIBITOR; CYCLOSPORIN; EDROPHONIUM; ETRETINATE; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; PYRIDOSTIGMINE; STEROID;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; DISEASE COURSE; ELECTROMYOGRAPHY; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LYMPHOBLASTOMA; MYASTHENIA GRAVIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SIBLING; SYMPTOM;

EID: 0033379175     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702067     Document Type: Article

References (16)

1. Smith CI, Aarli JA, Biberfield P et al. Myasthenia gravis after bone marrow transplantation. Evidence for a donor origin. New Engl J Meet 1983; 309: 1565-1568.
2. Seely E, Drachman D, Smith BR et al. Post bone marrow transplantation (BMT) myasthenia gravis: evidence for acetylcholine receptor (Ach R) abnormality. Blood 1984; 64 (Suppl. 1): 221a (Abstr. 793).
3. Bolger GB, Sullivan KM, Spence AM et al. Myasthenia chronic gravis after bone marrow transplantation: relationship to graft- versus-host disease. Neurology 1986; 36: 1087-1091.
4. Atkinson K, Bryant D, Delprado W, Biggs J. Widespread pulmonary fibrosis as a major clinical manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 129-132.
5. Grau JM, Casademont R, Monforte R et al. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant 1990; 5: 435-437.
6. Shimoda K, Gondo H, Harada M et al. Myasthenia gravis after bone marrow transplantation. Bone Marrow Transplant 1994; 14: 155-156.
7. Melms A, Faul C. Sommer N et al. Myasthenia gravis after BMT: identification of patients at risk? Bone Marrow Transplant 1992; 9: 78-79.
8. Zaja F, Russo D, Silvestri F et al. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 15: 649-653.
9. Adams C, August CS, Maguire H, Sladky JT. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995; 12: 58-61.
10. Hayashi M, Matsuda O, Ishida Y, Kida K. Change of immunological parameters in the clinical course of a myasthenia gravis patient with chronic graft-versus-host disease. Acta Paediatr Jpn 1996; 38: 151-155.
11. Mackey JR, Desai S, Larratt L et al. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997; 19: 939-942.
12. Baron F, Sadzot B, Wang F, Beguin Y. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 197-200.
13. Smith CI, Hammerstrom L, Lefvert AK. Bone-marrow grafting induces acetylcholine receptor antibody formation. Lancet 1985; 1: 978.
14. Smith CI, Norberg R, Moller G et al. Autoantibody formation after bone marrow transplantation. Eur Neurol 1989; 29: 128-134.
15. Horowitz MM, Rowlings PA. An update on the international bone marrow transplant registry and the autologous blood and marrow transplant registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997; 4: 395-400.
16. Lefvert AK. Bjorkholm M. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting. New Engl J Med 1987; 317: 170.